The MFDS requires healthcare professionals, manufacturers, and importers to report adverse events within specific timeframes. Serious adverse events must be reported immediately or within 15 days, while non-serious cases are reported quarterly. Reports must include patient details, drug information, and event description. This helps the MFDS monitor drug safety and take corrective actions.